A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 1,788 shares of NBIX stock, worth $223,500. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,788
Previous 1,788 -0.0%
Holding current value
$223,500
Previous $246,000 16.67%
% of portfolio
0.03%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$130.86 - $143.19 $9,160 - $10,023
-70 Reduced 3.77%
1,788 $246,000
Q1 2024

Apr 30, 2024

BUY
$130.4 - $143.74 $2,608 - $2,874
20 Added 1.09%
1,858 $256,000
Q4 2023

Jan 19, 2024

BUY
$106.07 - $132.76 $318 - $398
3 Added 0.16%
1,838 $242,000
Q3 2023

Oct 19, 2023

BUY
$94.02 - $117.1 $172,526 - $214,878
1,835 New
1,835 $206,000
Q4 2022

Jan 17, 2023

BUY
$106.72 - $127.06 $223,471 - $266,063
2,094 New
2,094 $0
Q2 2022

Jul 29, 2022

SELL
$75.79 - $100.07 $985 - $1,300
-13 Reduced 14.29%
78 $8,000
Q1 2022

May 11, 2022

BUY
$72.45 - $94.81 $3,767 - $4,930
52 Added 133.33%
91 $9,000
Q4 2021

Jan 10, 2022

SELL
$79.65 - $106.22 $3,982 - $5,311
-50 Reduced 56.18%
39 $3,000
Q3 2021

Nov 24, 2021

BUY
$86.18 - $99.03 $1,982 - $2,277
23 Added 34.85%
89 $9,000
Q2 2021

Jul 30, 2021

SELL
$89.43 - $102.27 $1,430 - $1,636
-16 Reduced 19.51%
66 $6,000
Q1 2021

Apr 29, 2021

SELL
$87.57 - $119.4 $1,926 - $2,626
-22 Reduced 21.15%
82 $8,000
Q4 2020

Jan 15, 2021

SELL
$86.91 - $108.33 $521 - $649
-6 Reduced 5.45%
104 $10,000
Q3 2020

Oct 21, 2020

BUY
$96.16 - $135.15 $480 - $675
5 Added 4.76%
110 $11,000
Q2 2020

Jul 10, 2020

BUY
$85.09 - $130.36 $1,701 - $2,607
20 Added 23.53%
105 $13,000
Q1 2020

Apr 15, 2020

BUY
$75.11 - $113.76 $6,384 - $9,669
85 New
85 $7,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.